AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026

B SHANGHAI, April 20, 2026 /PRNewswire/ — AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha radiotherapies, today announced that it…
posteditor
posteditor
Articles: 16137

Other News